Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-043032

EVP, Research & CSO acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-06-23 Option exercise +8,000 $1.53 $12,240 99,700 D
Derivatives
Virgin Herbert EVP, Research & CSO 2021-06-23 Option exercise · Stock Option (Right to Buy) −8,000 290,755 D
Loading xslF345X03/doc4.xml…